| Oct 23 |
US Medicaid programs say cost a key factor for weight-loss drug coverage, survey finds
|
| Oct 22 |
Why Novo Nordisk (NVO) Dipped More Than Broader Market Today
|
| Oct 22 |
Novo's Rybelsus CV results may not be clinically meaningful, Bernstein says
|
| Oct 22 |
Viking Therapeutics Stock Up 240% YTD: Can Q3 Earnings, Weight-Loss Drug Drive Further Gains?
|
| Oct 22 |
Novo Nordisk: Be Cautious About Buying The Dip
|
| Oct 22 |
NVO's Rybelsus Meets Primary Goal in MACE Study for Diabetes Patients
|
| Oct 22 |
5 Large Drug Stocks Likely to Outpace Q3 Earnings Estimates
|
| Oct 22 |
Novo Nordisk plans label expansion for Rybelsus following Phase III win
|
| Oct 21 |
Novo Nordisk's Rybelsus Sets New Standard: 14% Cut in Cardiovascular Risks for Diabetics
|
| Oct 21 |
NVO Stock Falls 5% in a Month: Should Investors Buy Now or Wait?
|
